According to Elevance Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.39. At the end of 2024 the company had a P/S ratio of 0.4867.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.4867 | -24.73% |
2023 | 0.6467 | -17.75% |
2022 | 0.7862 | -2.74% |
2021 | 0.8084 | 25.02% |
2020 | 0.6466 | -11.79% |
2019 | 0.7330 | -0.13% |
2018 | 0.7339 | 14.38% |
2017 | 0.6416 | 43.77% |
2016 | 0.4463 | -3.02% |
2015 | 0.4602 | 0.9% |
2014 | 0.4561 | 18.99% |
2013 | 0.3833 | 27.42% |
2012 | 0.3008 | -20.76% |
2011 | 0.3796 | 3.79% |
2010 | 0.3657 | -9.29% |
2009 | 0.4032 | 17.61% |
2008 | 0.3428 | -55.9% |
2007 | 0.7774 | -8.49% |
2006 | 0.8495 | -28.2% |
2005 | 1.18 | -29.21% |
2004 | 1.67 | 171.54% |
2003 | 0.6155 | -6.72% |
2002 | 0.6598 |